Keywords
Triamcinolone hexacetonide
Platelet-rich plasma (PRP)
Minoxidil
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the efficacy and safety of triamcinolone hexacetonide in the treatment of alopecia areata, comparing it with other therapeutic approaches and considering short- and long-term clinical outcomes. Methods: This is an integrative review analyzing the population with alopecia areata, exposed to different medications, namely: triamcinolone hexacetonide, PRP, or minoxidil. The searches were conducted in the PubMed Central (PMC) database, resulting in a total of 243 articles, which underwent a selection and classification process. Results: The selected articles showed that triamcinolone hexacetonide remains the first-line treatment, although it is a medication that is difficult to access in Brazil. Alternatives, proven by numerous studies, such as PRP, were presented as effective interventions, especially when combined with topical minoxidil. Final Considerations: It is concluded that triamcinolone is effective in the treatment of mild to moderate alopecia areata, but it presents significant side effects with prolonged use. Emerging therapies, such as PRP and minoxidil, offer promising alternatives with fewer risks and comparable results.
References
ALMOHANNA HM, et al. Platelet-rich plasma in the treatment of alopecia areata: a review. Journal of Investigative Dermatology Symposium Proceedings, 2020: S45-S49.
ANUDEEP TC, et al. Advancing regenerative cellular therapies in non-scarring alopecia. Pharmaceutics, 2022; 14(3): 612.
BALAKRISHNAN A, et al. A comparative study of therapeutic response to intralesional injections of platelet-rich plasma versus triamcinolone acetonide in alopecia areata. Indian dermatology online journal, 2020; 11(6): 920-924.
BARLETTA M, GASQUES L. Successful treatment of alopecia areata patches with triamcinolone acetonide using MMP®: report of 2 cases. Skin Appendage Disorders, 2020; 6(4): 229-234.
CHU TW, et al. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An ntrasubject pilot study. Journal of the American Academy of Dermatology, 2015; 73(2): 338-340.
CRUCIANI M, et al. Platelet-rich plasma for the treatment of alopecia: A systematic review and meta-analysis. Blood Transfusion, 2023; 21(1): 24.
DE SOUSA VB, et al. Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial. Journal of Dermatological Treatment, 2022; 33(2): 875-877.
EL TAIEB MA, et al. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation. Dermatologic therapy, 2017; 30(1): e12437.
GUPTA AK, et al. Monotherapy for alopecia areata: a systematic review and network meta-analysis. Skin appendage disorders, 2019; 5(6): 331-337.
JAFARZADEH A, et al. Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials. Stem Cell Research & Therapy, 2024; 15(1): 176.
KHAN FA, et al. Comparative Study Between Intralesional Injection Of Platelet Rich Plasma And Intra Lesional Triamcinolone For The Treatment Of Alopecia Areata. Journal of Ayub Medical College Abbottabad-Pakistan, 2022; 34(4).
MARCHITTO MC, et al. Emerging nonsteroid-based procedural therapies for alopecia areata: a systematic review. Dermatologic Surgery, 2019; 45(12): 1484-1506.
MARTORA F, et al. Oral minoxidil for chemotherapy-induced alopecia. Skin Appendage Disorders, 2022; 8(6): 508-510.
MUHAMMAD A, et al. Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches. Cureus, 2024; 16(6).
POTOTSCHNIG H, MADL MT. Successful treatment of alopecia areata barbae with platelet-rich plasma. Cureus, 2020; 12(4).
RAGAB SEM, et al. Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling. Acta Dermatovenerol Alp Pannonica Adriat, 2020; 29(4): 169-173.
RINALDI F, et al. Efficacy of postbiotics in a PRP-like cosmetic product for the treatment of alopecia area Celsi: a randomized double-blinded parallel-group study. Dermatology and therapy, 2020; 10: 483-493.
RUCHIATAN K, et al. Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil. Clinical, Cosmetic and Investigational Dermatology, 2022: 127-132.
SHIMIZU Y, et al. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Regenerative therapy, 2022; 21: 527-539.
STRAZZULLA LC, et al. An overview of the biology of platelet-rich plasma and microneedling as potential treatments for alopecia areata. Journal of Investigative Dermatology, 2017.
VAZQUEZ OA, et al. Alopecia areata treated with advanced platelet-rich fibrin using micronization. Plastic and Reconstructive Surgery–Global Open, 2022; 10(1): e4032.
WEI F, et al. Effect of minoxidil combined with triamcinolone acetonide on alopecia areata by microneedle injection. Skin Research and Technology, 2024; 30(4): e13713.